Pharmaceutical solid dose manufacturing companies in contract marketing segment have gained a vital position in pharmaceutical formulations. Pharmaceutical solid dosage forms are the most popular in the pharmaceutical industry and are one of the most used drug delivery methods across patient groups.
Streamlined development, flexibility in manufacturing, and improved product quality at reduced costs, while gaining access to capabilities and capacity are some of the factors fuelling the pharmaceutical solid dosage contract manufacturing market.
Find the leading pharmaceutical solid dose manufacturing companies in contract marketing
Pharmaceutical Technology has listed the top solid dose manufacturing companies and solid dose pharmaceutical companies based on our intel, insights and decades-long expertise in the sector. The companies offer various solid dose products and services including, but not limited to, formulation and analytical development, manufacturing capabilities, technology transfer and scale-up, quality and regulatory support, commercial manufacturing, packaging, and warehousing.
The list of pharmaceutical solid dose manufacturing companies includes providers of solid state and pre-formulation technologies, IND/NDA filing support, technologies for cGMP manufacturing of APIs and intermediates from lab to commercial scale, process optimisation, and designing and developing manufacturing processes.
The information contained within the download document is designed for pharmaceutical executives, pharmacists, research executives, formulation scientists, quality assurance coordinators, regulatory affairs officers, business development executives, research associates, managers and any other individual involved in the pharmaceutical solid dose manufacturing sector.
The download contains detailed information on the providers and their services and solutions, alongside contact details to aid your purchasing or hiring decision.
Growth of oral solid dosage contract manufacturing in the pharmaceutical industry
Drug manufacturers have been investing significantly in the R&D of more effective and patient-friendly solid forms. The development of increasingly complex molecules is driving the demand for more sophisticated manufacturing technologies and supply needs, making outsourcing an important component in the efficient commercial manufacturing of the products.
Contract development and manufacturing organisations are increasingly becoming an important part of oral solid dose drug development and manufacturing process for many small, medium as well as large pharma companies. Their end-to-end service offering provides an efficient manufacturing process and supports the improvement of supply chain efficiency.